• Citer

Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy.

par Piccart-Gebhart, Martine ;Floquet, A;Scarfone, G;Willemse, P H B;Emerich, J;Vergote, Ignace;Giurgea, L;Coens, C;Awada, Ahmad ;Vermorken, Jan Baptist
Référence International journal of gynecological cancer, 13 Suppl 2, page (196-203)
Publication Publié, 2003

Article révisé par les pairs

• Détails
• Contenu

Titre:	Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy.
Auteur:	Piccart-Gebhart, Martine; Floquet, A; Scarfone, G; Willemse, P H B; Emerich, J; Vergote, Ignace; Giurgea, L; Coens, C; Awada, Ahmad; Vermorken, Jan Baptist
Informations sur la publication:	International journal of gynecological cancer, 13 Suppl 2, page (196-203)
Statut de publication:	Publié, 2003
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antineoplastic Agents -- administration & dosage
	Cisplatin -- administration & dosage
	Disease-Free Survival
	Europe
	Female
	Humans
	Infusions, Intravenous
	Injections, Intraperitoneal
	Middle Aged
	Ovarian Neoplasms -- drug therapy
	Ovarian Neoplasms -- mortality
	Ovarian Neoplasms -- pathology
	Ovarian Neoplasms -- surgery
	Survival Analysis
	Treatment Outcome
Note générale:	Clinical Trial
	Clinical Trial, Phase III
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:1048-891X
	info:pii/13360
	info:pmid/14656280